OUP Management Company’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

OUP Management Company’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-268,346	Closed	-$12.5M	–	13
2023 Q2	$12.5M	Hold	268,346	–	–	21.26%	2
2023 Q1	$7.69M	Hold	268,346	–	–	15.34%	3
2022 Q4	$8.37M	Sell	268,346 -268,347	-50%	-$8.75M	13.67%	4
2022 Q3	$10.9M	Hold	536,693	–	–	16.95%	3
2022 Q2	$8.33M	Hold	536,693	–	–	11.46%	4
2022 Q1	$10.3M	Hold	536,693	–	–	7.82%	5
2021 Q4	$13.6M	Buy	+536,693	New	+$15.7M	6.12%	5

OUP Management Company's DICE Position: Q3 2023 in Review

OUP Management Company sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 268,346 shares — an estimated $12.5M sold.

OUP Management Company first reported a position in DICE in Q4 2021 and held it in 7 quarters. The position peaked at $13.6M in Q4 2021. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

OUP Management Company reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
OUP Management Company sold 268,346 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $12.5M.
OUP Management Company first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
OUP Management Company's DICE Therapeutics, Inc. Common Stock position peaked at $13.6M in Q4 2021.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on OUP Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.